Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Feb 26, 2022
Market Access

Moderna looks to subscriptions as future of vaccine business

The goal is to get countries to sign 10-year contracts for pre-specified volumes
BioCentury | Nov 13, 2021
Data Byte

CHMP opinions for November include KRAS inhibitor sotorasib

Two new COVID-19 mAbs among recommended
BioCentury | Dec 7, 2018
Clinical News

China approves Descovy, Harvoni, Hemlibra

BioCentury | Dec 4, 2018
Company News

China approves Descovy, Harvoni, Hemlibra

Items per page:
1 - 10 of 48